Richards Pleads Guilty to Charge of Receipt of Misbranded Drugs Imported from China
Posted on
Richards Imported 50 kilograms of Mislabeled Chloroquine from China with the Intent to Sell the Drug in the United States
SALT LAKE CITY – Daniel Kevin Richards, 37, of Sandy, Utah, pleaded guilty to receiving misbranded chloroquine from China with the intent to sell the drug in the United States. In the plea agreement, Richards admitted that, in April of 2020, he imported and received over 50 kilograms of misbranded and mislabeled chloroquine from China. Richards admitted that the chloroquine was falsely mislabeled as “Boswellia Serrata Extract” and that the drug was not manufactured and prepared by an establishment registered as a drug manufacturer with the Food and Drug Administration. Additionally, the labeling on the drugs failed to bear adequate directions for use as required by federal law. At sentencing, Richards faces a maximum possible sentence of up to a year in prison and a $100,000 fine. Richards has also agreed to pay for the destruction of the drug by the proper authorities at the conclusion of the case.